BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.76% |
| 2 | Healthcare | 6.75% |
| 3 | Financials | 5.74% |
| 4 | Consumer Discretionary | 5.28% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVA
2176
DELISTED
Covanta Holding Corporation
CVA
| $527K | ﹤0.01% |
61,683
+6,052
| +11% | +$81.6K |
|
|
VLRS
2177
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $527K | ﹤0.01% |
+153,700
| New | +$1.5M |
|
2178
CALL
Lennar Class A
LEN
$20.9B
| $527K | ﹤0.01% |
143
| – | – |
|
|
DCPH
2179
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $525K | ﹤0.01% |
12,751
-22,952
| -64% | -$1.27M |
|
|
UNVR
2180
DELISTED
Univar Solutions Inc.
UNVR
| $524K | ﹤0.01% |
48,887
-55,986
| -53% | -$1.04M |
|
2181
Capitol Federal Financial
CFFN
$1.08B
| $521K | ﹤0.01% |
44,849
+6,668
| +17% | +$85.4K |
|
2182
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $519K | ﹤0.01% |
21,715
+3,751
| +21% | +$112K |
|
|
ARI
2183
Apollo Commercial Real Estate
ARI
$876M
| $518K | ﹤0.01% |
69,839
+11,872
| +20% | +$185K |
|
2184
Rambus
RMBS
$10.9B
| $518K | ﹤0.01% |
46,625
+3,562
| +8% | +$49.3K |
|
2185
Global X US Preferred ETF
PFFD
$2.17B
| $516K | ﹤0.01% |
23,593
-8,001
| -25% | -$193K |
|
2186
B&G Foods
BGS
$294M
| $516K | ﹤0.01% |
28,507
+4,032
| +16% | +$63.2K |
|
2187
Laureate Education
LAUR
$5.18B
| $515K | ﹤0.01% |
48,955
+5,785
| +13% | +$100K |
|
|
CSII
2188
DELISTED
Cardiovascular Systems, Inc.
CSII
| $514K | ﹤0.01% |
14,595
+5,721
| +64% | +$241K |
|
2189
Choice Hotels
CHH
$4.7B
| $512K | ﹤0.01% |
8,361
+2,347
| +39% | +$213K |
|
2190
CALL
Analog Devices
ADI
$190B
| $511K | ﹤0.01% |
+57
| New | +$6.23K |
|
2191
Brink's
BCO
$4.71B
| $510K | ﹤0.01% |
9,806
-2,085
| -18% | -$163K |
|
|
P
2192
Everpure Inc
P
$39.3B
| $508K | ﹤0.01% |
41,277
-382,713
| -90% | -$6.2M |
|
|
LGTY
2193
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $507K | ﹤0.01% |
35,659
+30,189
| +552% | +$446K |
|
2194
CarGurus
CARG
$3.33B
| $506K | ﹤0.01% |
26,707
-72,135
| -73% | -$2.07M |
|
2195
National Vision
EYE
$1.53B
| $506K | ﹤0.01% |
26,036
+14,940
| +135% | +$465K |
|
2196
Kodiak Sciences
KOD
$2.59B
| $506K | ﹤0.01% |
10,599
+7,532
| +246% | +$452K |
|
2197
CALL
Stellantis
STLA
$20.2B
| $505K | ﹤0.01% |
+703
| New | +$8.33K |
|
|
2198
PUT
Stellantis
STLA
$20.2B
| $504K | ﹤0.01% |
+701
| New | +$8.31K |
|
2199
Quanex
NX
$962M
| $504K | ﹤0.01% |
49,978
+40,499
| +427% | +$645K |
|
|
NUAN
2200
PUT
DELISTED
Nuance Communications, Inc.
NUAN
| $503K | ﹤0.01% |
300
-2,921
| -91% | -$57.1K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.